Subscribe to STAT’s news feed.
Click on “Follow” and decide if you want to get news from STAT via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to STAT comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from STAT which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: STAT | Reporting from the frontiers of health and medicine
Is this your feed? Claim it!
The Food and Drug Administration on Thursday approved an oral treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of medicine for the blood cancer and the first drug cleared by U.S. regulators using a more sensitive measure of remission.
The Bristol drug, iberdomide, will be sold under the brand name Zenbexus. It w...
At a church on the outskirts of Liverpool, older residents amble in for community lunch. In Sunderland, mothers swap stories as they are guided through play exercises with their babies at a local hub. On the St Matthew’s estate in Leicester, children spill out of school and onto a new football pitch.
These scenes are unremarkable, the everyday rhythms of community l...
Methadone clinics are finally getting their report card.
In 2024, with the specialized addiction treatment providers facing backlash from patient groups and scrutiny from lawmakers, the federal government issued a long-awaited ove...
After doing three loops around the parking lot, you finally see a free spot. You step on the gas to claim it, but an SUV cuts in front of you and steals the space. You stomp on the brakes, jerking to a halt. You might forgive the other driver, but your Toyota remembers.
Later, as you drive home, your eyes wander to the restaurant that just opened on the corner. You...
The Trump administration’s campaign to eradicate transgender health care for young people has run into a series of legal roadblocks: Judges have ruled against Justice Department subpoenas, a